[HTML][HTML] Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria

R Peces, A Aguilar, C Vega, E Cuesta… - Nefrología (English …, 2012 - revistanefrologia.com
Antecedentes: En la poliquistosis renal autosómica dominante (PQRAD), la hematuria
macroscópica por la rotura de quistes renales es una manifestación habitual, que puede ser …

Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria.

R Peces, A Aguilar, C Vega, E Cuesta, C Peces… - …, 2012 - search.ebscohost.com
Correspondencia: Ramón Peces Servicio de Nefrología. Hospital Universitario La Paz.
IdiPAZ, Madrid. Spain. cpeces@ varnetmail. com function to treat severe haematuria poorly …

Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria

R Peces, A Aguilar, C Vega… - … oficial de la …, 2012 - pubmed.ncbi.nlm.nih.gov
Background Gross haematuria is a common manifestation of autosomal dominant polycystic
kidney disease (ADPKD). It can be spontaneous or the result of trauma, renal calculi …

Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria.

R Peces, A Aguilar, C Vega, E Cuesta… - … Publicacion Oficial de …, 2012 - europepmc.org
Background Gross haematuria is a common manifestation of autosomal dominant polycystic
kidney disease (ADPKD). It can be spontaneous or the result of trauma, renal calculi …

[PDF][PDF] Medical therapy with tranexamic acid in autosomal dominant polycystic kidney disease patients with severe haematuria

R Peces, A Aguilar, C Vega, E Cuesta, C Peces… - …, 2012 - revistanefrologia.com
Correspondencia: Ramón Peces Servicio de Nefrología. Hospital Universitario La Paz.
IdiPAZ, Madrid. Spain. cpeces@ varnetmail. com function to treat severe haematuria poorly …